AU2001234582A1 - Methods and materials relating to preadipocyte factor-1-like (pref-1-like) polypeptides and polynucleotides - Google Patents
Methods and materials relating to preadipocyte factor-1-like (pref-1-like) polypeptides and polynucleotidesInfo
- Publication number
- AU2001234582A1 AU2001234582A1 AU2001234582A AU3458201A AU2001234582A1 AU 2001234582 A1 AU2001234582 A1 AU 2001234582A1 AU 2001234582 A AU2001234582 A AU 2001234582A AU 3458201 A AU3458201 A AU 3458201A AU 2001234582 A1 AU2001234582 A1 AU 2001234582A1
- Authority
- AU
- Australia
- Prior art keywords
- polypeptide
- polynucleotide
- protein
- cells
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Physical Education & Sports Medicine (AREA)
- Cell Biology (AREA)
- Emergency Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Child & Adolescent Psychology (AREA)
- Endocrinology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US49140400A | 2000-01-25 | 2000-01-25 | |
US09491404 | 2000-01-25 | ||
US65100800A | 2000-08-29 | 2000-08-29 | |
US09651008 | 2000-08-29 | ||
PCT/US2001/002611 WO2001057233A2 (en) | 2000-01-25 | 2001-01-25 | Methods and materials relating to preadipocyte factor-1-like (pref-1-like) polypeptides and polynucleotides |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001234582A1 true AU2001234582A1 (en) | 2001-08-14 |
Family
ID=27050422
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001234582A Abandoned AU2001234582A1 (en) | 2000-01-25 | 2001-01-25 | Methods and materials relating to preadipocyte factor-1-like (pref-1-like) polypeptides and polynucleotides |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1261736A4 (ja) |
JP (1) | JP2003521928A (ja) |
AU (1) | AU2001234582A1 (ja) |
CA (1) | CA2398215A1 (ja) |
WO (1) | WO2001057233A2 (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007523592A (ja) * | 2002-12-27 | 2007-08-23 | アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ | 新規前駆脂肪細胞因子−1様ポリペプチド |
BRPI0708363A2 (pt) | 2006-03-09 | 2011-05-24 | Om Pharma | processo para o tratamento de animais de sangue quente, incluindo seres humanos, sofrendo de uma doença relativa a uma superprodução de citocinas inflamatórias |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003513662A (ja) * | 1999-11-09 | 2003-04-15 | ヒューマン ジノーム サイエンシーズ, インコーポレイテッド | 15個のヒト分泌タンパク質 |
JP2004500100A (ja) * | 2000-03-06 | 2004-01-08 | スミスクライン・ビーチャム・コーポレイション | 新規化合物 |
-
2001
- 2001-01-25 JP JP2001558045A patent/JP2003521928A/ja not_active Withdrawn
- 2001-01-25 CA CA002398215A patent/CA2398215A1/en not_active Abandoned
- 2001-01-25 WO PCT/US2001/002611 patent/WO2001057233A2/en not_active Application Discontinuation
- 2001-01-25 EP EP01906704A patent/EP1261736A4/en not_active Withdrawn
- 2001-01-25 AU AU2001234582A patent/AU2001234582A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2398215A1 (en) | 2001-08-09 |
WO2001057233A2 (en) | 2001-08-09 |
EP1261736A2 (en) | 2002-12-04 |
JP2003521928A (ja) | 2003-07-22 |
EP1261736A4 (en) | 2004-12-29 |
WO2001057233A3 (en) | 2002-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1346040A2 (en) | Novel nucleic acids and polypeptides | |
WO2001075067A2 (en) | Novel nucleic acids and polypeptides | |
US20110268724A1 (en) | Methods and materials relating to cd84-like polypeptides and polynucleotides | |
WO2001053454A9 (en) | Methods and materials relating to g protein-coupled receptor-like polypeptides and polynucleotides | |
WO2002016439A2 (en) | Novel nucleic acids and polypeptides | |
EP1254266A1 (en) | Methods and materials relating to alpha-2-macroglobulin-like polypeptides and polynucleotides | |
AU2001234865A1 (en) | Methods and materials relating to alpha-2-macroglobulin-like polypeptides and polynucleotides | |
AU2001232969A1 (en) | Methods and materials relating to transforming growth factor alpha-like polypeptides and polynucleotides | |
WO2001055335A2 (en) | Methods and materials relating to leukocyte immunoglobulin receptor-like (lir-like) polypeptides and polynucleotides | |
AU2001233003A1 (en) | Methods and materials relating to leukocyte immunoglobulin receptor-like (lir-like) polypeptides and polynucleotides | |
EP1574520A2 (en) | Methods and materials relating to neuronal guidance molecule-like (NGM-like) polypeptides and polynucleotides | |
WO2001057266A1 (en) | Methods and materials relating to alpha-2-macroglobulin-like polypeptides and polynucleotides | |
WO2001053456A9 (en) | Methods and materials relating to prothrombinase-like polypeptides and polynucleotides | |
WO2002072138A1 (en) | Methods and materials relating to fibulin-like polypeptides and polynucleotides | |
US20040122220A1 (en) | Methods and materials relating to preadipocyte factor-1-like (pref-1-like) polypeptides and polynucleotides | |
WO2001055337A2 (en) | Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides | |
WO2001053326A1 (en) | Methods and materials relating to phospholipase-like polypeptides and polynucleotides | |
AU2001234582A1 (en) | Methods and materials relating to preadipocyte factor-1-like (pref-1-like) polypeptides and polynucleotides | |
WO2001057260A1 (en) | Methods and materials relating to scavenger receptor-like polypeptides and polynucleotides | |
AU2001234848A1 (en) | Methods and materials relating to metallocarboxypeptidase-like polypeptides and polynucleotides | |
WO2001057267A1 (en) | Methods and materials relating to cub domain polypeptides and polynucleotides | |
WO2001053466A1 (en) | Methods and materials relating to semaphorin-like polypeptides and polynucleotides | |
WO2001055334A2 (en) | Methods and materials relating to immunoglobulin domain-containing polypeptides and polynucleotides | |
EP1242580A1 (en) | Methods and materials relating to semaphorin-like polypeptides and polynucleotides |